Published in Int J Hepatol on July 03, 2012
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet (2016) 1.63
Advances in the management of acute liver failure. World J Gastroenterol (2013) 0.91
An Update on Treatment of Drug-Induced Liver Injury. J Clin Transl Hepatol (2014) 0.81
Application of the Liver Maximum Function Capacity Test in Acute Liver Failure: A Helpful Tool for Decision-Making in Liver Transplantation? Case Rep Transplant (2016) 0.75
Acute hepatorenal failure in a patient following consumption of mushrooms: a case report. Iran Red Crescent Med J (2015) 0.75
Mycetismus: a review. Gastroenterol Rep (Oxf) (2015) 0.75
Predictors of poor outcomes in patients with wild mushroom-induced acute liver injury. World J Gastroenterol (2017) 0.75
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol (2006) 3.14
Indication of liver transplantation following amatoxin intoxication. J Hepatol (2005) 2.24
Mushroom poisoning--from diarrhea to liver transplantation. Am J Gastroenterol (2001) 1.93
Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol (2002) 1.49
New aspects of amanita poisoning. Klin Wochenschr (1979) 1.27
Cytotoxic fungi--an overview. Toxicon (2003) 1.26
Clinical symptomatology and management of mushroom poisoning. Toxicon (1993) 1.26
Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother (2004) 1.19
Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol (2001) 1.18
Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol (2001) 1.14
Kinetics of amatoxins in human poisoning: therapeutic implications. J Toxicol Clin Toxicol (1993) 1.13
Mycotoxins revisited: Part I. J Emerg Med (2005) 1.10
Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology (1997) 1.05
A new look at an old problem: mushroom poisoning. Clinical presentations and new therapeutic approaches. Am J Med (1975) 1.03
Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp Toxicol (1994) 0.95
Silybin inhibition of amatoxin uptake in the perfused rat liver. Arzneimittelforschung (1980) 0.94
Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol (1983) 0.93
Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning. Liver Int (2003) 0.90
Toxins of Amanita phalloides. Toxicon (1998) 0.90
Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Clin Toxicol (Phila) (2011) 0.85
Toxicokinetics of labeled amatoxins in the dog. Arch Toxicol (1985) 0.85
Mushrooms, amatoxins and the liver. J Hepatol (2005) 0.83
Therapy of cytotoxic mushroom intoxication. Crit Care Med (1985) 0.82
Amanita toxins in gastroduodenal fluid of patients poisoned by the mushroom, Amanita phalloides. N Engl J Med (1979) 0.82
Selection for emergency liver transplantation. J Hepatol (1993) 0.82
Lethal ingestion of stored Amanita phalloides mushrooms. Swiss Med Wkly (2001) 0.81
Ultrastructural changes in beta-cells of pancreatic islets in alpha-amanitin-poisoned mice. Virchows Arch B Cell Pathol (1978) 0.81
Is MARS system enough for A. phalloides-induced liver failure treatment? Hum Exp Toxicol (2010) 0.81
The insensitivity of mushroom nuclear RNA polymerase activity to inhibition by amatoxins. Arch Microbiol (1978) 0.81
Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain. J Hepatol (2004) 0.80
Disseminated intravascular coagulation and mesenteric venous thrombosis in fatal Amanita poisoning. Hum Toxicol (1988) 0.80
Diagnostic accuracy of urinary amanitin in suspected mushroom poisoning: a pilot study. J Toxicol Clin Toxicol (2004) 0.80
Amanitins do not bind to serum albumin. Lancet (1977) 0.77
Mushroom poisoning. Compr Ther (1982) 0.77
Hepatotoxic mushroom poisoning: diagnosis and management. Mycopathologia (1989) 0.77
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology (2012) 2.46
Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology (2012) 2.38
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver Int (2012) 1.56
Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology (2013) 1.17
A novel model of CCl4-induced cirrhosis with ascites in the mouse. J Hepatol (2009) 1.10
Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol (2006) 1.08
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. Dig Liver Dis (2013) 1.02
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol (2003) 0.92
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol (2007) 0.92
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis. Lab Invest (2011) 0.92
Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med (2013) 0.90
Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis. Hepatology (2014) 0.88
The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives. Liver Int (2013) 0.87
Human albumin in the management of complications of liver cirrhosis. Crit Care (2012) 0.86
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol (2011) 0.86
Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant (2004) 0.86
Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. J Hepatol (2009) 0.85
QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol (2012) 0.85
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. Gastroenterology (2009) 0.84
Portal vein arterialization in a patient with acute liver failure. Transplantation (2005) 0.82
Role of p38 map kinase in glycine-induced hepatocyte resistance to hypoxic injury. J Hepatol (2006) 0.82
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. J Hepatol (2005) 0.81
Pancreatic resection in patients 80 years or older: a meta-analysis and systematic review. Pancreas (2014) 0.81
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? Liver Int (2013) 0.80
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. J Surg Res (2006) 0.80
Systemic and regional hemodynamics in pre-ascitic cirrhosis: effects of posture. J Hepatol (2003) 0.80
Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A. Br J Pharmacol (2012) 0.79
Soluble receptor activator of nuclear factor- kappaB Ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases. Biogerontology (2004) 0.79
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury. ScientificWorldJournal (2012) 0.79
Transcatheter embolization for giant splenic artery aneurisms: still an open question. Case Rep Radiol (2012) 0.76
Reply: To PMID 22095893. Hepatology (2014) 0.75
Liver Cirrhosis in a Patient with Sickle Cell Trait (Hb Sβ Thalassemia) without Other Known Causes of Hepatic Disease. Case Rep Gastroenterol (2009) 0.75
Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: relationship with renal function. Scand J Gastroenterol (2007) 0.75
[Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis]. Recenti Prog Med (2011) 0.75
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. Dig Liver Dis (2013) 0.75
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF). Dig Liver Dis (2013) 0.75
Routine blood tests? Helping you live(r) longer! Lancet (2011) 0.75